Back to search
FDAFDA · Food and drugs·Recall number Z-1785-2019

Liquid Cardiac Control, Model Nos. CQ5051, CQ5052, CQ5053

Published June 26, 2019 · Recall initiated: March 11, 2019

Summary

FDA records medical device Class II recall Z-1785-2019, published June 26, 2019 and initiated March 11, 2019. Recalling firm: Randox Laboratories Ltd.; Status: Terminated; Reported quantity: 11420 kits; Lot: lots 4243CK, 4244CK, 4245CK. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Customers may observe a decrease in recovered concentration with regards to NTproBNP in the Liquid Cardiac Control lots identified, on the Siemens Dimension EXL LOCI.

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Randox Laboratories Ltd.
Distributor
Product distributed to CA, DE, WV, and Puerto Rico.
Lot
lots 4243CK, 4244CK, 4245CK.
Risk classification
Class II
Area (FDA)
device
Country
Ireland

Related recalls

Questions about this recall

Was Liquid Cardiac Control, Model Nos. CQ5051, CQ5052, CQ5053 recalled?

Yes. FDA published recall Z-1785-2019 on June 26, 2019. Reported hazard: Customers may observe a decrease in recovered concentration with regards to NTproBNP in the Liquid Cardiac Control lots identified, on the Siemens Dimension EXL LOCI.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail